These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37949858)

  • 1. Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization.
    Lurette O; Martín-Jiménez R; Khan M; Sheta R; Jean S; Schofield M; Teixeira M; Rodriguez-Aller R; Perron I; Oueslati A; Hebert-Chatelain E
    Cell Death Dis; 2023 Nov; 14(11):729. PubMed ID: 37949858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein.
    Martinez JH; Alaimo A; Gorojod RM; Porte Alcon S; Fuentes F; Coluccio Leskow F; Kotler ML
    Mol Cell Neurosci; 2018 Apr; 88():107-117. PubMed ID: 29414102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.
    Artyukhova MA; Tyurina YY; Chu CT; Zharikova TM; Bayır H; Kagan VE; Timashev PS
    Free Radic Biol Med; 2019 Nov; 144():279-292. PubMed ID: 31201850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
    Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
    J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease.
    Geibl FF; Henrich MT; Xie Z; Zampese E; Ueda J; Tkatch T; Wokosin DL; Nasiri E; Grotmann CA; Dawson VL; Dawson TM; Chandel NS; Oertel WH; Surmeier DJ
    Mol Neurodegener; 2024 Oct; 19(1):69. PubMed ID: 39379975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
    Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
    Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIAH proteins regulate the degradation and intra-mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease.
    Abd Elghani F; Safory H; Hamza H; Savyon M; Farhoud M; Toren-Hershoviz M; Vitic Z; Ebanks K; Shani V; Bisharat S; Shaulov L; Brodski C; Song Z; Bandopadhyay R; Engelender S
    Aging Cell; 2022 Dec; 21(12):e13731. PubMed ID: 36307912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synuclein.
    Paine SM; Anderson G; Bedford K; Lawler K; Mayer RJ; Lowe J; Bedford L
    PLoS One; 2013; 8(1):e54711. PubMed ID: 23382946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
    Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson's disease.
    Muwanigwa MN; Modamio-Chamarro J; Antony PMA; Gomez-Giro G; Krüger R; Bolognin S; Schwamborn JC
    Mol Cell Neurosci; 2024 Mar; 128():103919. PubMed ID: 38307302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.
    Chen J; Ren Y; Gui C; Zhao M; Wu X; Mao K; Li W; Zou F
    Cell Death Dis; 2018 Jun; 9(6):700. PubMed ID: 29899409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson's models.
    Shaltouki A; Hsieh CH; Kim MJ; Wang X
    Acta Neuropathol; 2018 Oct; 136(4):607-620. PubMed ID: 29923074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.